相关实验视频
Updated: Feb 5, 2026

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.6K
在疾病发作时预测儿科慢性免疫血小板缺血的发展,使用统计风险模型
Kirsty Hillier1, Mark Zobeck2, Derek MacMath3
1Hassenfeld Children's Hospital at NYU Langone Health, NYU Grossman School of Medicine, New York, New York, United States.
Blood
|February 3, 2026
概括
一个新的模型预测了儿童慢性免疫血小板缺血症 (ITP). 它使用年龄,性别和初始血液计数等因素来识别患有长期疾病风险的患者,帮助早期管理.
科学领域:
- 儿科血液学 儿科血液学
- 免疫学 免疫学 免疫学
- 生物统计学 生物统计学
背景情况:
- 儿童免疫性血小板缺血 (ITP) 的过程是不可预测的,高达30%的人患有慢性疾病.
- 慢性ITP的已知预测因子有限,使早期临床管理和患者咨询复杂化.
- 在ITP中免疫失调的复杂病理生理学有助于疾病的慢性化.
研究的目的:
- 开发和验证一个统计模型,用于预测儿童慢性免疫血栓塞缩症 (ITP) 的发展.
- 确定与ITP慢性相关的关键临床和实验室变量.
- 为儿童ITP提供早期风险分层的工具.
主要方法:
- 用611名患有ITP的儿童组成的培训队列来开发一个多变量逻辑回归模型.
- 模型的验证使用两个外部队列,共161名儿童.
- 包括年龄,性别,免疫球蛋白水平 (IgG,IgA,IgM),呈现血小板和淋巴细胞计数,次要原因和DAT阳性等变量.
主要成果:
- 开发的模型有效地预测了慢性ITP的发展.
- 确定的主要预测因素包括年龄,性别,IgG,IgA,IgM,呈现血小板计数,呈现淋巴细胞计数,诊断时的次要原因和DAT阳性.
- 外部验证证实了该模型的一致的歧视性性能和临床实用性.
结论:
- 一个经验证的多变量模型可以在诊断时预测儿童的慢性ITP.
- 这种预测工具可以帮助血液学家咨询家庭,并定制早期治疗策略.
- 在线工具 (https://opal.shinyapps.io/citp-rm/) 可用于临床使用.
相关概念视频
Statistical Significance
21.9K
Once data is collected from both the experimental and the control groups, a statistical analysis is conducted to find out if there are meaningful differences between the two groups. A statistical analysis determines how likely any difference found is due to chance (and thus not meaningful). In psychology, group differences are considered meaningful, or significant, if the odds that these differences occurred by chance alone are 5 percent or less. Stated another way, if we repeated this...
21.9K
Chronic Kidney Disease I: Introduction
733
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
733
Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.5K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.8K
Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K

